Fmoc-glu-OAll

CAS: 144120-54-7

Ref. 3D-FF41629

Produktinformation

• Name: Fmoc-glu-OAll
• Synonyme: (4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-prop-2-enoxypentanoic acid, (4S)-4-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-oxo-5-(prop-2-en-1-yloxy)pentanoic acid (non-preferred name), 1-(2-Propen-1-yl) hydrogen N-[(9H-fluoren-9-ylmethoxy)carbonyl]-<span class="text-smallcaps">L</span>-glutamate, <span class="text-smallcaps">L</span>-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-(2-propen-1-yl) ester, <span class="text-smallcaps">L</span>-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-(2-propenyl) ester, Fmoc-Glu-OAll, Fmoc-Glu-allyl ester, Fmoc-L-glutamic acid α-allyl ester
• CAS: 144120-54-7

Beschreibung

Fmoc-glu-OAll is a cyclic peptide that is synthesized using solid-phase synthesis. It has been shown to have minimal inhibitory concentration (MIC) values of 0.5 µg/mL against mouse tumor cells and human serum, as well as high affinity for integrin receptors. This peptide also binds to the human serum albumin and blood clotting factor Xa, which are proteins involved in cancer therapy.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 409.43 g/mol
• Formel: C₂₃H₂₃NO₆
• Reinheit: Min. 95%
• InChl: InChI=1S/C23H23NO6/c1-2-13-29-22(27)20(11-12-21(25)26)24-23(28)30-14-19-17-9-5-3-7-15(17)16-8-4-6-10-18(16)19/h2-10,19-20H,1,11-14H2,(H,24,28)(H,25,26)/t20-/m0/s1
• InChI Key: InChIKey=ORKKMGRINLTBPC-FQEVSTJZSA-N
• SMILES: C=CCOC(=O)[C@H](CCC(=O)O)NC(=O)OCC1c2ccccc2-c2ccccc21